Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Net income | -$15.6M | -$50.3M | -$57.9M | -$63.7M | -$70.8M | -$59.0M |
| EPS (diluted) | -$0.54 | -$0.60 | -$0.46 | -$0.51 | -$0.56 | -$0.47 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$14.0M | -$39.2M | -$45.8M | -$51.7M | -$59.1M | -$50.7M |
| Capital expenditures | $921K | $2.27M | $2.32M | $2.44M | $2.12M | $1.28M |
| Free cash flow | -$14.9M | -$41.5M | -$48.1M | -$54.2M | -$61.3M | -$52.0M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $36.6M | $186M | $115M | $19.4M | $27.6M | $12.4M |
| Total assets | $85.0M | $398M | $350M | $306M | $243M | $191M |
| Total liabilities | $6.31M | $34.9M | $35.1M | $40.2M | $34.0M | $34.1M |
| Shareholders' equity | -$29.7M | $364M | $315M | $265M | $209M | $157M |
| Retained earnings | -$30.3M | -$80.6M | -$139M | -$202M | -$273M | -$332M |
| Shares (wtd avg diluted) | 29.1M | 84.5M | 125M | 125M | 125M | 126M |
Every figure is extracted from Nautilus Biotechnology, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.